Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/14/2005EP1603390A2 Microbicidal compositions including an ionene polymer and 2,4,4'-trichloro-2'-hydroxydiphenyl ether, and methods of using the same
12/14/2005EP1534283B1 Formulation of liposomal derivatives of phenylalanine
12/14/2005EP1527084A4 Promoters exhibiting endothelial cell specificity and methods of using same
12/14/2005EP1509228B1 Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators
12/14/2005EP1496902B1 Medicament containing steroids and a novel anticholinergic drug
12/14/2005EP1492766A4 Improved cc-1065 analog synthesis
12/14/2005EP1469938B1 Apparatus and process for preparing crystalline particles
12/14/2005EP1450786B1 Isoflavone concentrate and method for production thereof
12/14/2005EP1440052B1 Benzamide derivatives as antagonists of orexin receptors
12/14/2005EP1439847A4 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract
12/14/2005EP1438290B1 Cyclohept b!indole derivatives as spla2 inhibitors
12/14/2005EP1429786A4 D-mannose contraceptives
12/14/2005EP1427709B1 3-substituted-4-pyrimidone derivatives
12/14/2005EP1417189B1 Acylaminothiazole derivatives, their preparation and therapeutic use
12/14/2005EP1405074A4 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
12/14/2005EP1370144A4 Noninvasive measurements of chemical substances
12/14/2005EP1359928B1 Medicinal and cosmetic use of hop and co-enzyme q10
12/14/2005EP1357870A4 Bioadhesive cell foam film of sustained-release delivery
12/14/2005EP1330428B1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride
12/14/2005EP1326858B1 Piperidine compounds as anti-allergic
12/14/2005EP1326845B1 N-alkoxyalkyl-substituted benzimidazoles and the use thereof as an agent against parasitic protozoans
12/14/2005EP1311296B1 Solution of an oxazolidinone antibiotic drug
12/14/2005EP1307207A4 Extended type 1 chain glycosphingolipids as tumor-associated antigens
12/14/2005EP1296669B1 Combination preparation consisting of omega-3-fatty acids and of conjugated linoleic acids for treating immunologically oriented clinical signs
12/14/2005EP1284771B1 Aerosol container for formulations of salmeterol xinafoate
12/14/2005EP1274430B1 Cabergoline for the treatment of fibromyalgia and chronic fatigue syndrome
12/14/2005EP1267880B1 Low dose entecavir formulation and use
12/14/2005EP1267803B1 Compositions and methods for treating hair loss using c16 - c20 aromatic tetrahydro prostaglandins
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005EP1261309B1 Device for calculating elixir doses appropriate for a patient's weight
12/14/2005EP1259923B1 Anti-infective agents useful against mulitidrug-resistant strains of bacteria
12/14/2005EP1255870B1 5-hydroxytryptamine transporter gene polymorphisms
12/14/2005EP1248594B1 Multi-spike release formulation for drug delivery
12/14/2005EP1247526B1 Perfusion liquid preparations for ophthalmic operations
12/14/2005EP1227084B1 Drug discharge pump inhibitors
12/14/2005EP1223931B1 Use of a imidazole derivative for the treatment or prevention of hypotension and shock
12/14/2005EP1222175B1 4,5-disubstituted-2-aminopyrimidines
12/14/2005EP1148870A4 Anti-plaque emulsions and products containing same
12/14/2005EP1121355B1 Quinoline derivatives and their use as antibacterial agents
12/14/2005EP1119562B1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
12/14/2005EP1115403B1 Method for optimizing the use of 6-mercaptopurine in the treatment of immune-mediated gastrointestinal disorders
12/14/2005EP1114160B1 Moraxella catarrhalis basb034 polypeptides and uses thereof
12/14/2005EP1112255B1 4,4-biarylpiperidine derivatives with opioid receptor activity
12/14/2005EP1107812B1 Gelatinous body protection article having a therapeutic additive
12/14/2005EP1082103B1 Spill resistant pharmaceutical compositions
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP1007714B1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
12/14/2005EP1007047B1 Use of mizolastine for preparing a medicine for treating inflammation
12/14/2005EP0970198B1 Micro-organisms with increased production of clavulanic acid
12/14/2005EP0927045B1 Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/14/2005EP0858504B1 Diagnostics and treatments of periodontal disease
12/14/2005EP0831782B1 Methods and system for processing dispersible fine powders
12/14/2005EP0765357B1 Antiviral dendrimers
12/14/2005EP0506830B1 Uncharged morpholino-based polymers having phosphorous-containing chiral intersubunit linkages
12/14/2005CN1708540A High-molecular weight derivatives of camptothecins
12/14/2005CN1708506A Polysaccharide vaccine for staphylococcal infections
12/14/2005CN1708499A Purine compounds and use thereof as cannabinoid receptor ligands
12/14/2005CN1708495A Heterocyclic compounds and antitumor drugs containing the same as the active ingredient
12/14/2005CN1708492A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1708480A Carotenoid analogs for the inhibition and amelioration of disease
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708331A Formulations containing melatonin, ginkgo biloba, and biotin
12/14/2005CN1708312A New alpha-glucosidase inhibitors from a natural source
12/14/2005CN1708310A Anticancer or antiviral composition
12/14/2005CN1708309A Therapeutic and/or preventive agent for dyschezia
12/14/2005CN1708308A Use of fosinopril to reduce cardiovascular events in dialysis patients
12/14/2005CN1708307A Water-soluble meloxicam granules
12/14/2005CN1708306A Quinazolinone compounds as calcilytics
12/14/2005CN1708305A Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure
12/14/2005CN1708304A Use of piperazine sulfonic acid derivatives as CCR1 antagonists for the treatment of fibrosis, alzheimer disease and other disorders
12/14/2005CN1708302A Pharmacological treatment for sleep apnea
12/14/2005CN1708301A Daily melatonin dosing units
12/14/2005CN1708300A Peroral preparation for prevention of or treatment for atopic dermatitis
12/14/2005CN1708299A Nerve fiber regeneration accelerator
12/14/2005CN1708298A Combination comprising a CDK inhibitor and cisplatin
12/14/2005CN1708297A Acetyl-l-carnitine for the prevention and/or treatment of peripheral neuropathies induced by anticancer agents
12/14/2005CN1708296A Combinations of anti-cancer agents
12/14/2005CN1708295A Pharmaceutical solutions of modafinil compounds and use in preparation of medicine for treatment of diseases
12/14/2005CN1708294A Combination of a CDK inhibitor and mitoxantrone
12/14/2005CN1708293A S1p receptor agonist for treating demyelinate disease
12/14/2005CN1708291A Transdermal therapeutic system provided with improved long-term carrying comfort
12/14/2005CN1708270A Propofol with cysteine
12/14/2005CN1708269A Compositions and methods for transdermal oxybutynin therapy
12/14/2005CN1708238A Method of removing caffeine from caffeine-containing catechin compound composition
12/14/2005CN1708236A Use of pullulan as a slowly digested carbohydrate
12/14/2005CN1706855A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same
12/14/2005CN1706847A Process for preparing 10alpha-[4'-(s,s-dioxothiomorpholin-1'-yl)]-10-deoxo-10-dihydroartemisinin
12/14/2005CN1706838A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/14/2005CN1706833A Formyl peptide-like acceptor-1 regulator and its prepn and use
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1706397A Composition of paeoniflorin and peony lactone glycoside with function of increasing leukocyte
12/14/2005CN1706396A Orally taken Bi-dredging prepn containing notoginseng glycol saponin and its prepn process and application
12/14/2005CN1706395A Prepn process of compound LDL-ACM medicine for treating cancer in digestive system
12/14/2005CN1706394A Compound monoammonium glycyrrhizunate S prepn for injection and its prepn process and quality control technology
12/14/2005CN1706393A Pyronaridine capsule as antimalarial medicine
12/14/2005CN1706392A Prepn process of pyronaridine capsule as antimalarial medicine
12/14/2005CN1706391A Terramycin suspension emulsion
12/14/2005CN1706390A Wet scabies treating ointment and its compounding process
12/14/2005CN1706389A Effervescent cefdinir prepn and its prepn process
12/14/2005CN1706388A New antibiotic composition
1 ... 4436 4437 4438 4439 4440 4441 4442 4443 4444 4445 4446 4447 4448 4449 4450 4451 4452 4453 4454 4455 4456 ... 7860